DE69906934D1 - Arzneizubereitungen - Google Patents

Arzneizubereitungen

Info

Publication number: DE69906934D1
Authority: DE; Germany
Prior art keywords: pharmaceutical preparations; preparations; pharmaceutical
Prior art date: 1998-02-06
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

DE69906934T

Other languages

English (en)

Other versions

DE69906934T2 (de

Inventor

Thoennes Brooks

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Glaxo Group Ltd

Original Assignee

Glaxo Group Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-02-06

Filing date

1999-02-04

Publication date

2003-05-22

1999-02-04 Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd

2003-05-22 Application granted granted Critical

2003-05-22 Publication of DE69906934D1 publication Critical patent/DE69906934D1/de

2004-02-12 Publication of DE69906934T2 publication Critical patent/DE69906934T2/de

2019-02-05 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Oil, Petroleum & Natural Gas (AREA)
Molecular Biology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Virology (AREA)
Organic Chemistry (AREA)
Immunology (AREA)
Communicable Diseases (AREA)
Bioinformatics & Cheminformatics (AREA)
Oncology (AREA)
Biochemistry (AREA)
AIDS & HIV (AREA)
Tropical Medicine & Parasitology (AREA)
Transplantation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

DE69906934T 1998-02-06 1999-02-04 Arzneizubereitungen Expired - Lifetime DE69906934T2 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GB9802472		1998-02-06
GBGB9802472.2A GB9802472D0 (en)	1998-02-06	1998-02-06	Pharmaceutical compositions
PCT/EP1999/000663 WO1999039691A2 (en)	1998-02-06	1999-02-04	Pharmaceutical compositions

Publications (2)

Publication Number	Publication Date
DE69906934D1 true DE69906934D1 (de)	2003-05-22
DE69906934T2 DE69906934T2 (de)	2004-02-12

Family

ID=10826520

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DE69906934T Expired - Lifetime DE69906934T2 (de)	1998-02-06	1999-02-04	Arzneizubereitungen

Country Status (39)

Country	Link
US (1)	US6641843B1 (de)
EP (1)	EP1051156B1 (de)
JP (1)	JP3560550B2 (de)
KR (1)	KR100564854B1 (de)
CN (2)	CN1296406A (de)
AP (1)	AP1212A (de)
AR (1)	AR017455A1 (de)
AT (1)	ATE237309T1 (de)
AU (1)	AU754255B2 (de)
BR (1)	BR9907649A (de)
CA (1)	CA2319010C (de)
CO (1)	CO5070673A1 (de)
CZ (1)	CZ299608B6 (de)
DE (1)	DE69906934T2 (de)
DK (1)	DK1051156T3 (de)
EA (1)	EA002916B1 (de)
EE (1)	EE04217B1 (de)
ES (1)	ES2196779T3 (de)
GB (1)	GB9802472D0 (de)
HK (1)	HK1030552A1 (de)
HR (1)	HRP20000530B1 (de)
HU (1)	HU228315B1 (de)
ID (1)	ID26215A (de)
IL (2)	IL137403A0 (de)
IS (1)	IS2200B (de)
MA (1)	MA26604A1 (de)
MY (1)	MY121043A (de)
NO (1)	NO329041B1 (de)
NZ (1)	NZ505811A (de)
PE (1)	PE20000271A1 (de)
PL (1)	PL194558B1 (de)
PT (1)	PT1051156E (de)
RS (1)	RS49953B (de)
SI (1)	SI1051156T1 (de)
SK (1)	SK284397B6 (de)
TR (1)	TR200002293T2 (de)
TW (1)	TWI222878B (de)
WO (1)	WO1999039691A2 (de)
ZA (1)	ZA99890B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2080511A3 (de) *	2000-08-22	2009-09-30	Shire LLC	Aktivmittelzufuhrsysteme und Verfahren zum Schutz und zur Lieferung von Aktivmitteln
US8394813B2 (en)	2000-11-14	2013-03-12	Shire Llc	Active agent delivery systems and methods for protecting and administering active agents
US7169752B2 (en)	2003-09-30	2007-01-30	New River Pharmaceuticals Inc.	Compounds and compositions for prevention of overdose of oxycodone
EP2085397A1 (de)	2008-01-21	2009-08-05	Esteve Quimica, S.A.	Kristalline Form von Abacavir
EP2305680A3 (de) *	2009-09-30	2011-05-18	Aurobindo Pharma Limited	Neuartige Salze von (1S,4R)-cis-4-[2-amino-6-(cyclopropylamin)-9H-purin-9-yl]-2-cyclopenten-1-methanol
CN104788451A (zh) *	2014-01-21	2015-07-22	浙江九洲药业股份有限公司	一种阿巴卡韦的制备方法
CN105315280A (zh) *	2014-06-06	2016-02-10	上海迪赛诺化学制药有限公司	一种阿巴卡韦结晶体及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5567703A (en)	1988-01-20	1996-10-22	Regents Of The University Of Minnesota	Method for treating HIV infections with dideoxycarbocyclic nucleosides
US5631370A (en)	1988-01-20	1997-05-20	Regents Of The University Of Minnesota	Optically-active isomers of dideoxycarbocyclic nucleosides
GB8815265D0 (en)	1988-06-27	1988-08-03	Wellcome Found	Therapeutic nucleosides
MY104575A (en) *	1989-12-22	1994-04-30	The Wellcome Foundation Ltd	Therapeutic nucleosides.
GB9417249D0 (en) *	1994-08-26	1994-10-19	Wellcome Found	A novel salt
KR20000022225A (ko) *	1996-06-25	2000-04-25	그레이엄 브레레톤;레슬리 에드워즈	Hiv 치료에 사용하기 위한 vx478, 지도부딘 및(또는)1592u89를 포함하는 배합물
US6124319A (en) *	1997-01-21	2000-09-26	Merck & Co., Inc.	3,3-disubstituted piperidines as modulators of chemokine receptor activity
US6177464B1 (en) *	1997-03-14	2001-01-23	Sepracor, Inc.	Ring opening metathesis of alkenes
GB9709945D0 (en) *	1997-05-17	1997-07-09	Glaxo Group Ltd	A novel salt

1998
- 1998-02-06 GB GBGB9802472.2A patent/GB9802472D0/en not_active Ceased
1999
- 1999-02-02 TW TW088101534A patent/TWI222878B/zh not_active IP Right Cessation
- 1999-02-03 AR ARP990100439A patent/AR017455A1/es active IP Right Grant
- 1999-02-03 PE PE1999000088A patent/PE20000271A1/es not_active IP Right Cessation
- 1999-02-04 EE EEP200000459A patent/EE04217B1/xx unknown
- 1999-02-04 AU AU27221/99A patent/AU754255B2/en not_active Expired
- 1999-02-04 WO PCT/EP1999/000663 patent/WO1999039691A2/en active IP Right Grant
- 1999-02-04 AT AT99907477T patent/ATE237309T1/de active
- 1999-02-04 ZA ZA9900890A patent/ZA99890B/xx unknown
- 1999-02-04 PL PL99342628A patent/PL194558B1/pl unknown
- 1999-02-04 DK DK99907477T patent/DK1051156T3/da active
- 1999-02-04 US US09/601,671 patent/US6641843B1/en not_active Expired - Lifetime
- 1999-02-04 PT PT99907477T patent/PT1051156E/pt unknown
- 1999-02-04 CA CA002319010A patent/CA2319010C/en not_active Expired - Lifetime
- 1999-02-04 NZ NZ505811A patent/NZ505811A/xx not_active IP Right Cessation
- 1999-02-04 KR KR1020007008595A patent/KR100564854B1/ko not_active IP Right Cessation
- 1999-02-04 TR TR2000/02293T patent/TR200002293T2/xx unknown
- 1999-02-04 IL IL13740399A patent/IL137403A0/xx active IP Right Grant
- 1999-02-04 CZ CZ20002867A patent/CZ299608B6/cs not_active IP Right Cessation
- 1999-02-04 HU HU0100802A patent/HU228315B1/hu unknown
- 1999-02-04 EP EP99907477A patent/EP1051156B1/de not_active Expired - Lifetime
- 1999-02-04 MY MYPI99000389A patent/MY121043A/en unknown
- 1999-02-04 JP JP2000530191A patent/JP3560550B2/ja not_active Expired - Lifetime
- 1999-02-04 BR BR9907649-7A patent/BR9907649A/pt not_active Application Discontinuation
- 1999-02-04 ES ES99907477T patent/ES2196779T3/es not_active Expired - Lifetime
- 1999-02-04 SK SK1168-2000A patent/SK284397B6/sk not_active IP Right Cessation
- 1999-02-04 CO CO99006407A patent/CO5070673A1/es unknown
- 1999-02-04 DE DE69906934T patent/DE69906934T2/de not_active Expired - Lifetime
- 1999-02-04 RS YUP-482/00A patent/RS49953B/sr unknown
- 1999-02-04 AP APAP/P/2000/001878A patent/AP1212A/en active
- 1999-02-04 ID IDW20001507A patent/ID26215A/id unknown
- 1999-02-04 SI SI9930271T patent/SI1051156T1/xx unknown
- 1999-02-04 EA EA200000736A patent/EA002916B1/ru not_active IP Right Cessation
- 1999-02-04 MA MA25452A patent/MA26604A1/fr unknown
- 1999-02-04 CN CN99804843A patent/CN1296406A/zh active Pending
- 1999-02-04 CN CNA2008100838827A patent/CN101239063A/zh active Pending
2000
- 2000-07-19 IL IL137403A patent/IL137403A/en not_active IP Right Cessation
- 2000-07-20 IS IS5569A patent/IS2200B/is unknown
- 2000-08-04 HR HR20000530A patent/HRP20000530B1/xx not_active IP Right Cessation
- 2000-08-04 NO NO20003962A patent/NO329041B1/no not_active IP Right Cessation
2001
- 2001-03-06 HK HK01101617A patent/HK1030552A1/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
TR200002293T2 (tr)	2000-11-21
RS49953B (sr)	2008-09-29
NO329041B1 (no)	2010-08-02
PT1051156E (pt)	2003-09-30
TWI222878B (en)	2004-11-01
GB9802472D0 (en)	1998-04-01
NO20003962D0 (no)	2000-08-04
MY121043A (en)	2005-12-30
US6641843B1 (en)	2003-11-04
CA2319010A1 (en)	1999-08-12
EE200000459A (et)	2002-02-15
CZ20002867A3 (cs)	2001-02-14
EP1051156B1 (de)	2003-04-16
EA200000736A1 (ru)	2001-04-23
PE20000271A1 (es)	2000-04-17
SI1051156T1 (en)	2003-08-31
IS2200B (is)	2007-02-15
CA2319010C (en)	2008-06-10
MA26604A1 (fr)	2004-12-20
PL342628A1 (en)	2001-06-18
EP1051156A2 (de)	2000-11-15
WO1999039691A3 (en)	1999-10-28
HK1030552A1 (en)	2001-05-11
HU228315B1 (en)	2013-03-28
AP2000001878A0 (en)	2000-09-30
PL194558B1 (pl)	2007-06-29
AP1212A (en)	2003-11-12
ATE237309T1 (de)	2003-05-15
IL137403A0 (en)	2001-07-24
EE04217B1 (et)	2004-02-16
NZ505811A (en)	2002-09-27
CZ299608B6 (cs)	2008-09-17
HUP0100802A2 (hu)	2001-08-28
DE69906934T2 (de)	2004-02-12
KR100564854B1 (ko)	2006-03-30
HUP0100802A3 (en)	2001-12-28
AU754255B2 (en)	2002-11-07
ZA99890B (en)	2000-08-04
SK11682000A3 (sk)	2001-04-09
CN101239063A (zh)	2008-08-13
JP2002502808A (ja)	2002-01-29
SK284397B6 (sk)	2005-03-04
AU2722199A (en)	1999-08-23
IS5569A (is)	2000-07-20
DK1051156T3 (da)	2003-06-23
CN1296406A (zh)	2001-05-23
EA002916B1 (ru)	2002-10-31
ES2196779T3 (es)	2003-12-16
BR9907649A (pt)	2000-10-31
KR20010040714A (ko)	2001-05-15
AR017455A1 (es)	2001-09-05
HRP20000530A2 (en)	2001-02-28
YU48200A (sh)	2003-02-28
IL137403A (en)	2007-07-24
CO5070673A1 (es)	2001-08-28
ID26215A (id)	2000-12-07
HRP20000530B1 (en)	2003-10-31
NO20003962L (no)	2000-09-27
WO1999039691A2 (en)	1999-08-12
JP3560550B2 (ja)	2004-09-02

Publication	Publication Date	Title
IS5953A (is)	2001-05-25	Lyfjablöndur úr örgerðum eplerenonum
NO992339L (no)	1999-11-16	Farmasöytiske formuleringer
IS6040A (is)	2001-08-07	Valdekoxib efnablöndur
DK0921796T3 (da)	2001-07-16	Tetrahydrolipstatinholdige præparater
NO20020304L (no)	2002-03-21	Konserverte farmasoytiske preparater
NO20071303L (no)	2001-07-27	Farmasoytiske preparater
ID24654A (id)	2000-07-27	Formulasi farmasi omeprazola
NO20001776L (no)	2000-06-06	Medikamenter
NO20005218D0 (no)	2000-10-17	Farmasøytisk aerosolpreparat
NO20012915L (no)	2001-08-13	Ny farmasöytisk formulering
ID29089A (id)	2001-07-26	Sediaan farmasi moksifloksasin
DK1466615T3 (da)	2009-08-31	Farmaceutisk præparat
NO980546D0 (no)	1998-02-09	Farmasöytiske midler
ATE266383T1 (de)	2004-05-15	Dermatologische zubereitungen
ATE332132T1 (de)	2006-07-15	Verbesserte arzneizubereitungen enthaltend ritonavir
ID27150A (id)	2001-03-08	Sediaan levotiroksin bahan farmasi
ID16781A (id)	1997-11-13	Formulasi-formulasi farmasi
DE69926012D1 (de)	2005-08-04	Arzneizubereitungen
NO994619D0 (no)	1999-09-23	Farmasöytiske blandinger
ATE246494T1 (de)	2003-08-15	Brausezubereitungen
NO20003141D0 (no)	2000-06-16	Farmasøytiske blandinger
DE69906934D1 (de)	2003-05-22	Arzneizubereitungen
EE200100697A (et)	2003-02-17	Farmatseutiline kompleks
DE50009295D1 (de)	2005-02-24	Vernetzerfreie zubereitungen
ID23531A (id)	2000-04-27	Komposisi farmasi

Legal Events

Date	Code	Title	Description
2004-05-13	8364	No opposition during term of opposition